Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$5.44 0.01 (0.18%)
2/9/2010 3:59 PM

Bioform Medical (BFRM)

CAPS Rating:
*

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BFRM

Add Stock to Watchlist

What the Community Thinks

Total Members

45 Outperforms
12 Underperforms
 

All-Stars

23 Outperforms
7 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on BFRM are also bullish on:

Members bearish on BFRM are also bearish on:

Ticker Tags

Healthcare (711), Pharmaceuticals (149), Aggressive Growth (860), Defensive (1457), Micro Cap (4701), Growth (1902), IPO in 2007 (211)
Suggest a tag

Bioform Medical At A Glance

Current Price: $5.44
Last Trade Time: 2/9/2010 3:59 PM
Open: $5.44
Previous Close: $5.44
Daily Range: $5.44 - $5.45
52-Week Range: $0.88 - $5.70
Volume: 108,181
Market Cap: $252.89M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

BFRM VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Bioform Medical (BFRM)

Avatar sb101cu (< 20) Submitted: 8/30/08 11:14 PM


I have seen a pattern that if a stock has five star CAPS rating AND is near the lower end of the 52 week range, then the stock ALWAYS appreciates by 25 % over the next three months.
I would appreciate if other fools have also noticed this and would correct me if I am wrong

Replies: 1 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 4 of 4  

Show Pitch Replies

Recs

0

 (BFRM)

Avatar kurzzz (92.68) Submitted: 10/09/08 8:32 AM : Outperform Start Price: $2.17 BFRM Score: 140.26

Nowhere to go but up

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (BFRM)

Avatar sb101cu (< 20) Submitted: 8/30/08 11:14 PM : Outperform Start Price: $4.17 BFRM Score: 45.43


I have seen a pattern that if a stock has five star CAPS rating AND is near the lower end of the 52 week range, then the stock ALWAYS appreciates by 25 % over the next three months.
I would appreciate if other fools have also noticed this and would correct me if I am wrong

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (BFRM)

Avatar betabata (< 20) Submitted: 3/05/08 2:38 PM : Outperform Start Price: $5.61 BFRM Score: 13.02

wrinkle filler

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BFRM)

Avatar MD4Beauty (< 20) Submitted: 11/13/07 5:01 PM : Outperform Start Price: $8.40 BFRM Score: -10.52

Bioform markets a dermal filler, Radiesse, which has potential to take market share from Restylane by Medicis. New techniques have been developed which make the injections less painful and easier to perform. The company has priced the product well to compete with other fillers and will be supplying new, thinner (read: less painful) needles with the product in the near future, pending FDA approval.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 4 of 4  

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackPiperJaff 85.79 11/04/09 Outperform NS $4.04+34.65%+3.35%+31.30
TrackJPMorgan 84.76 12/17/07 Outperform NS $7.82-30.43%-23.38%-7.05

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 750ms